| dc.description.abstract | Background. Timely reperfusion for the treatment of ST-elevation myocardial infarction (STEMI) is the primary goal to achieve substantial myocardial salvage. However, in developing countries, patients often do not have immediate access to a cardiologist and centre therefore causing delay in presenting and impacting the outcomes of patients. Data on the characteristics and outcomes of STEMI patients treated with percutaneous coronary intervention (PCI) in developing countries including Indonesia remains limited. Objective. The aim of this study was to determine the demographic, clinical, laboratory and outcomes of STEMI patients who underwent percutaneous coronary intervention at H. Adam Malik General Hospital, Indonesia. Methods. This is a retrospective study of 60 patients with STEMI admitted from January to April 2023 to H. Adam Malik General Hospital, Indonesia. Demographic data, clinical, and outcomes of patients were collected from the medical records. Demographic data such as age, sex, smoking status, family history of cardiovascular disease (CVD) and stroke was recorded. Admission clinical and laboratory information including blood pressure, lipid status, blood glucose, and type of PCI performed and blood vessels involved were also collated. Outcomes were determined according to the numbers of hospitalization days, and clinical outcomes of recovered or death. Analysis on the association between demographic, clinical, and laboratory parameters with outcomes were performed. Results and Discussion. From the frequency distribution calculation, most of the samples are men (81.7%), aged 50-59 years (35%), alive (88.3%), duration of hospitalization ≤5 days (76.7%), smoking (75%), affected by LAD blood vessels (51.1%) and through PCI procedures with PTCA + Stent type (98.3%). Conclusion. The results of this study show the involvement of CVD risk factors and lifestyle with the incidence of STEMI and the high success of PCI treatment. | en_US |
